Breast cancer risk characteristics of women undergoing whole‐breast ultrasound screening versus mammography alone

Author:

Sprague Brian L.123ORCID,Ichikawa Laura4,Eavey Joanna4,Lowry Kathryn P.5ORCID,Rauscher Garth6,O’Meara Ellen S.4,Miglioretti Diana L.47,Chen Shuai7ORCID,Lee Janie M.5,Stout Natasha K.8,Mandelblatt Jeanne S.9ORCID,Alsheik Nila10,Herschorn Sally D.23,Perry Hannah23,Weaver Donald L.311,Kerlikowske Karla1213

Affiliation:

1. Office of Health Promotion Research Department of Surgery University of Vermont Larner College of Medicine Burlington Vermont USA

2. Department of Radiology University of Vermont Larner College of Medicine Burlington Vermont USA

3. University of Vermont Cancer Center University of Vermont Larner College of Medicine Burlington Vermont USA

4. Kaiser Permanente Washington Health Research Institute Seattle Washington USA

5. Department of Radiology University of Washington and Seattle Cancer Care Alliance Seattle Washington USA

6. Division of Epidemiology and Biostatistics School of Public Health University of Illinois at Chicago Chicago Illinois USA

7. Division of Biostatistics Department of Public Health Sciences University of California Davis Davis California USA

8. Department of Population Medicine Harvard Medical School and Harvard Pilgrim Health Care Institute Boston Massachusetts USA

9. Department of Oncology Georgetown University Medical Center Georgetown University Washington District of Columbia USA

10. Advocate Caldwell Breast Center Advocate Lutheran General Hospital Park Ridge Illinois USA

11. Department of Pathology & Laboratory Medicine University of Vermont Larner College of Medicine Burlington Vermont USA

12. Departments of Medicine and Epidemiology and Biostatistics University of California San Francisco California USA

13. General Internal Medicine Section Department of Veterans Affairs University of California San Francisco California USA

Abstract

AbstractBackgroundThere are no consensus guidelines for supplemental breast cancer screening with whole‐breast ultrasound. However, criteria for women at high risk of mammography screening failures (interval invasive cancer or advanced cancer) have been identified. Mammography screening failure risk was evaluated among women undergoing supplemental ultrasound screening in clinical practice compared with women undergoing mammography alone.MethodsA total of 38,166 screening ultrasounds and 825,360 screening mammograms without supplemental screening were identified during 2014–2020 within three Breast Cancer Surveillance Consortium (BCSC) registries. Risk of interval invasive cancer and advanced cancer were determined using BCSC prediction models. High interval invasive breast cancer risk was defined as heterogeneously dense breasts and BCSC 5‐year breast cancer risk ≥2.5% or extremely dense breasts and BCSC 5‐year breast cancer risk ≥1.67%. Intermediate/high advanced cancer risk was defined as BCSC 6‐year advanced breast cancer risk ≥0.38%.ResultsA total of 95.3% of 38,166 ultrasounds were among women with heterogeneously or extremely dense breasts, compared with 41.8% of 825,360 screening mammograms without supplemental screening (p < .0001). Among women with dense breasts, high interval invasive breast cancer risk was prevalent in 23.7% of screening ultrasounds compared with 18.5% of screening mammograms without supplemental imaging (adjusted odds ratio, 1.35; 95% CI, 1.30–1.39); intermediate/high advanced cancer risk was prevalent in 32.0% of screening ultrasounds versus 30.5% of screening mammograms without supplemental screening (adjusted odds ratio, 0.91; 95% CI, 0.89–0.94).ConclusionsUltrasound screening was highly targeted to women with dense breasts, but only a modest proportion were at high mammography screening failure risk. A clinically significant proportion of women undergoing mammography screening alone were at high mammography screening failure risk.

Funder

Agency for Healthcare Research and Quality

National Institute of General Medical Sciences

National Cancer Institute

Patient-Centered Outcomes Research Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3